2型糖尿病患者におけるDPP-4阻害薬を用いた多剤併用療法の実施状況と短期治療成績(JDDM-29)

Lauren C Brown, Jeffrey A Johnson, Scot H Simpson, JM Gamble, Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis Open Medicine. ,vol. 2, pp. 26- 38 ,(2008)

Masashi Kobayashi, Katsuya Yamazaki, Koichi Hirao, Mariko Oishi, Azuma Kanatsuka, Mikio Yamauchi, Hirofumi Takagi, Koichi Kawai, The status of diabetes control and antidiabetic drug therapy in Japan—A cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1) Diabetes Research and Clinical Practice. ,vol. 73, pp. 198- 204 ,(2006) , 10.1016/J.DIABRES.2006.01.013

K. Hermansen, M. Kipnes, E. Luo, D. Fanurik, H. Khatami, P. Stein, , Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diabetes, Obesity and Metabolism. ,vol. 9, pp. 733- 745 ,(2007) , 10.1111/J.1463-1326.2007.00744.X

Chang-Liang Zhang, Megumi Katoh, Tadao Shibasaki, Kohtaro Minami, Yasuhiro Sunaga, Harumi Takahashi, Norihide Yokoi, Masahiro Iwasaki, Takashi Miki, Susumu Seino, The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs Science. ,vol. 325, pp. 607- 610 ,(2009) , 10.1126/SCIENCE.1172256

J. Rosenstock, D. Sugimoto, P. Strange, J. A. Stewart, E. Soltes-Rak, G. Dailey, , Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care. ,vol. 29, pp. 554- 559 ,(2006) , 10.2337/DIACARE.29.03.06.DC05-0695

Eri Mukai, Shimpei Fujimoto, Hiroki Sato, Chitose Oneyama, Rieko Kominato, Yuichi Sato, Mayumi Sasaki, Yuichi Nishi, Masato Okada, Nobuya Inagaki, Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner. Diabetes. ,vol. 60, pp. 218- 226 ,(2011) , 10.2337/DB10-0021

H. Yokoyama, K. Kawai, M. Kobayashi, , Microalbuminuria Is Common in Japanese Type 2 Diabetic Patients A nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10) Diabetes Care. ,vol. 30, pp. 989- 992 ,(2007) , 10.2337/DC06-1859

J. E. Lafata, E. A. Dobie, G. W. Divine, M. E. Ulcickas Yood, B. D. McCarthy, Sustained hyperglycemia among patients with diabetes: what matters when action is needed? Diabetes Care. ,vol. 32, pp. 1447- 1452 ,(2009) , 10.2337/DC08-2028